as of 12-05-2025 3:59pm EST
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
| Founded: | 1887 | Country: | Ireland |
| Employees: | N/A | City: | DUBLIN 2 |
| Market Cap: | 1.8B | IPO Year: | 1991 |
| Target Price: | $22.50 | AVG Volume (30 days): | 4.1M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -0.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.17 - $30.93 | Next Earning Date: | 11-05-2025 |
| Revenue: | $4,281,800,000 | Revenue Growth: | -2.51% |
| Revenue Growth (this year): | -0.95% | Revenue Growth (next year): | -0.55% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$14.18
Shares
7,500
Total Value
$106,350.00
Owned After
17,375
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Parker Geoffrey M. | PRGO | Director | Nov 12, 2025 | Buy | $14.18 | 7,500 | $106,350.00 | 17,375 |
See how PRGO stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PRGO Perrigo Company plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.